David A. Sallman

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

David A. Sallman

May 28, 2025, 07:21 | Blog

Talha Badar: SELECT-MDS-1 - Tamibarotene Plus Azacitidine in High-Risk MDS

Talha Badar, Hematology/Oncology specialist at Mayo Clinic, posted on X: "SELECT-MDS-1 Phase 3 Study of…

Mar 2, 2025, 08:51 | Blog

Joshua Zeidner: Magrolimab plus Azacitidine vs Physician Choice in Newly Diagnosed TP53-mut AML

Joshua Zeidner, Associate Professor at UNC Lineberger, shared on X about recent paper he and…

Sep 2, 2024, 09:01 | Insight

Mrinal Patnaik: ARNA shielding of P65 is required to potentiate oncogenic inflammation in TET2 mutated clonal hematopoiesis

Mrinal Patnaik, Physician Scientist with the Division of Hematology, Department of Internal Medicine at Mayo…

Jul 9, 2024, 00:57 | Insight

Talha Badar: Outcome after stopping venetoclax and azacitidine

Talha Badar shared on X: “American Journal of Hematology, Blood Research Journal, Wiley Online Library.…

All: 4 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023